SOFIA (Bulgaria), November 2 (SeeNews) – Bulgarian veterinary drugs producer Biovet [BUL:53B] said its non-consolidated net profit rose to 6.3 million levs ($4.1 million/3.2 million euro) in the first nine months of 2012 from 1.9 million levs a year earlier.